Company: DK
Filing Date: 2025-11-07
Form Type: 10-Q
Source: 0001628280-25-050541
Chunk: 25

Company: Delek US Holdings, Inc.
Filing Date: 2025-11-07
Form: 10-Q
Item: Part I, Item 1
Chunk 25
---
) from continuing operations$195.1 $(134.8)$(52.4)$(197.0)Less: Income from continuing operations attributed to non-controlling interests16.8 9.3 47.3 27.8 Numerator for basic and diluted EPS from continuing operations attributable to Delek$178.3 $(144.1)$(99.7)$(224.8)Numerator for EPS - discontinued operations(Loss) income from discontinued operations, including gain on sale of discontinued operations$(0.4)$95.4 $(1.8)$107.8 Less: Income tax (benefit) expense(0.1)28.1 (0.4)29.6 (Loss) income from discontinued operations, net of tax$(0.3)$67.3 $(1.4)$78.2 Denominator:Weighted average common shares outstanding (denominator for basic EPS)60,190,054 64,063,609 60,930,537 64,099,700 Dilutive effect of stock-based awards754,846 — — — Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS)60,944,900 64,063,609 60,930,537 64,099,700 EPS:Basic income (loss) per share:Income (loss) from continuing operations$2.96 $(2.25)$(1.64)$(3.51)Income (loss) from discontinued operations— 1.05 (0.02)1.22 Total basic income (loss) per share$2.96 $(1.20)$(1.66)$(2.29)Diluted income (loss) per share:Income (loss) from continuing operations$2.93 $(2.25)$(1.64)$(3.51)Income (loss) from discontinued operations— 1.05 (0.02)1.22 Total diluted income (loss) per share$2.93 $(1.20)$(1.66)$(2.29)The following equity instruments were excluded from the diluted weighted average common shares outstanding because their effect would be anti-dilutive:Antidilutive stock-based compensation (because average share price is less than exercise price)895,945 3,085,861 2,127,024